How have RHK shares performed in 2024?

RHÖN-KLINIKUM Aktiengesellschaft's stock was trading at €10.00 at the beginning of 2024. Since then, RHK stock has increased by 8.0% and is now trading at €10.80. View the best growth stocks for 2024 here .

Is RHÖN-KLINIKUM Aktiengesellschaft a good dividend stock?

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) pays an annual dividend of €0.15 per share and currently has a dividend yield of 1.36%. The dividend payout ratio is 30.61%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of RHÖN-KLINIKUM Aktiengesellschaft own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RHÖN-KLINIKUM Aktiengesellschaft investors own include Seabridge Gold (SA) , iShares Silver Trust (SLV) , Walt Disney (DIS) , Alamos Gold (AGI) , Warriedar Resources (AWV) , Bayerische Motoren Werke Aktiengesellschaft (BMW) , Anheuser-Busch InBev SA/NV (BUD) , Cognex (CGNX) , Canadian National Railway (CNI) and Warner Bros. Discovery (DISCK) .

ETR:RHK

RHÖN-KLINIKUM Aktiengesellschaft (RHK) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free RHK Stock Alerts

€10.80

-0.30 (-2.70%)

(As of 04/17/2024 ET)

Compare

Today's Range: €10.80
▼
€11.00
50-Day Range: €9.60
▼
€12.30
52-Week Range: €9.50
▼
€13.70

Volume: 439 shs
Average Volume: 43,281 shs
Market Capitalization: $722.95 million

P/E Ratio: 22.04
Dividend Yield: 1.39%
Price Target: N/A

Stock Analysis Chart

Get RHÖN-KLINIKUM Aktiengesellschaft alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About RHÖN-KLINIKUM Aktiengesellschaft Stock (ETR:RHK)

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

RHK Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RHK Stock News Headlines

April 14, 2024 | americanbankingnews.com

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Shares Up 1.8%

May 12, 2022 | finanznachrichten.de

Zukunft des UKGM: Rhön-Klinikum stellt Einigung infrage

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 25, 2022 | finanznachrichten.de

Rhön-Klinikum kommt gut durchs Corona-Jahr 2021

March 25, 2022 | uk.finance.yahoo.com

RHÖN-KLINIKUM AG looks back on successful financial year 2021

February 19, 2022 | finanznachrichten.de

Warum Technik und Medizin gut zusammenpassen - RHÖN fördert praxisorientierte Studien- und Berufsorientierung

February 19, 2022 | finanznachrichten.de

RHÖN-KLINIKUM Campus Bad Neustadt ist TAVI-Zentrum

See More Headlines

Receive RHK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RHÖN-KLINIKUM Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ETR
Sector: Medical
Industry: Medical Care Facilities
Sub-Industry: N/A
Current Symbol: ETR:RHK
CUSIP: N/A
CIK: N/A
Web: www.rhoen-klinikum-ag.com
Phone: +49-9-771650
Fax: N/A
Employees: 18,158
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): €0.49
Trailing P/E Ratio: 22.04
Forward P/E Ratio: 38.79
P/E Growth: 26.77
Net Income: $31.92 million
Net Margins: 1.87%
Pretax Margin: N/A
Return on Equity: 2.62%
Return on Assets: 1.08%

Debt

Debt-to-Equity Ratio: 11.89
Current Ratio: 2.28
Quick Ratio: 2.12

Sales & Book Value

Annual Sales: $1.71 billion
Price / Sales: 0.42
Cash Flow: €3.93 per share
Price / Cash Flow: 2.75
Book Value: €19.14 per share
Price / Book: 0.56

Miscellaneous

Outstanding Shares: 66,940,000
Free Float: N/A
Market Cap: $722.95 million
Optionable: Not Optionable
Beta: -0.01

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Dr. Tobias Kaltenbach (Age 64)
Chairman of Management Board
Comp: $547k
Dr. Stefan Stranz (Age 47)
CFO & Member of Management Board
Comp: $668k
Dr. Gunther Karl Weiß M.Sc. (Age 56)
COO & Member of Management Board
Comp: $708k
Julian Schmitt
Head of Investor Relations & Treasury
Mr. Eugen Münch
Chief Representative

Key Competitors

View All Competitors

RHK Stock Analysis - Frequently Asked Questions

How have RHK shares performed in 2024?: RHÖN-KLINIKUM Aktiengesellschaft's stock was trading at €10.00 at the beginning of 2024. Since then, RHK stock has increased by 8.0% and is now trading at €10.80.
View the best growth stocks for 2024 here.
Is RHÖN-KLINIKUM Aktiengesellschaft a good dividend stock?: RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) pays an annual dividend of €0.15 per share and currently has a dividend yield of 1.36%. The dividend payout ratio is 30.61%. This payout ratio is at a healthy, sustainable level, below 75%.
What other stocks do shareholders of RHÖN-KLINIKUM Aktiengesellschaft own?: Based on aggregate information from My MarketBeat watchlists, some companies that other RHÖN-KLINIKUM Aktiengesellschaft investors own include Seabridge Gold (SA), iShares Silver Trust (SLV), Walt Disney (DIS), Alamos Gold (AGI), Warriedar Resources (AWV), Bayerische Motoren Werke Aktiengesellschaft (BMW), Anheuser-Busch InBev SA/NV (BUD), Cognex (CGNX), Canadian National Railway (CNI) and Warner Bros. Discovery (DISCK).

This page (ETR:RHK) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial